Articles by Albert S. Li, MD

Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor Use

Journal of Neuro-Ophthalmology. 36(4):480-481, December 2016.

• Favorite
• PDF
• Permissions

• Free